The purpose of this study is to determine the effect of tranexamic acid (on blood loss and
transfusion requirements in patients with proximal humeral fractures requiring open surgical
approaches.
This a blinded, controlled, therapeutic trial in which the patients will be randomized to
receive TXA or no drug intervention. The primary outcome is the estimated total blood loss.
This study presents only minimal risks for the included patients.